Worldwide variation of dialysis-associated peritonitis in children

Kidney International

Volumn 72, Issue 11, 2007, Pages 1374-1379

  Schaefer, F ^a,n   Feneberg, R ^a   Aksu, N ^b   Donmez, O ^c   Sadikoglu, B ^d   Alexander, S R ^e   Mir, S ^f   Ha, I S ^g   Fischbach, M ^h   Simkova, E ⁱ   Watson, A R ^j   Moller K ^k   Von Baum, H ^l   Warady, B A ^m  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Tepecik Training and Research Hospital ^*  (Turkey)

^c ULUDAG UNIVERSITY   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

^e STANFORD UNIVERSITY   (United States)

^f EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^g Seoul National University Children's Hospital   (South Korea)

^h Strasbourg University Hospitals   (France)

ⁱ UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^j NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l UNIVERSITY OF ULM   (Germany)

^m CHILDREN S MERCY HOSPITAL   (United States)

ⁿ Center for Pediatrics and Adolescent Medicine   (Germany)

more..

Author keywords

Antibiotics; Dialysis; Global; Pediatric; Peritonitis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GLYCOPEPTIDE; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; EASTERN EUROPE; EUROPE; GEOGRAPHIC DISTRIBUTION; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; INCIDENCE; PEDIATRICS; PERITONEAL DIALYSIS; PERITONITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS; TREATMENT OUTCOME; UNITED STATES;

EID: 36248964169     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002523     Document Type: Article

References (9)

1. Feneberg R, Warady BA, Alexander SR et al. The international pediatric peritonitis registry: a global Internet-based initiative in pediatric dialysis. Perit Dial Int 2005; 25(Suppl 3): S130-S134.
2. Warady BA, Schaefer F, Holloway M et al. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int 2000; 10: 610-624.
3. de Freitas DG, Gokal R. Sterile peritonitis in the peritoneal dialysis patient. Perit Dial Int 2006; 26: 284.
4. Troidle L, Finkelstein F. Treatment and outcome of CPD-associated peritonitis. Ann Clin Microbiol Antimicrob 2006; 5: 6.
5. Kent JR, Almond MK. A survey of CAPD peritonitis management and outcomes in North and South Thames NHS regions (UK): support for the ISPD guidelines. International Society for Peritoneal Dialysis. Perit Dial Int 2000; 20: 301-305.
6. Schaefer F, Klaus G, Müller-Wiefel DE et al. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. J Am Soc Nephrol 1999; 10: 136-145.
7. Tacconelli E, Carmeli Y, Aizer A et al. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37: 1629-1638.
8. Piraino B. Preventing peritoneal dialysis related infections. Minerva Urol Nefrol 2006; 58: 161-169.
9. Verrina E, Honda M, Warady BA et al. Prevention of peritonitis in children on peritoneal dialysis. Perit Dial Int 2000; 20: 625-630.